Understanding Cannabis-Based Therapeutics in Sports Medicine

SCC Member Gretchen E. Maurer, DO, MS and colleagues examine the current research potential for cannabis in sports medicine.

Cannabis Medicinal en Latinoamérica: del Laboratorio a la Clínica

El evento inaugural del Capítulo Colombia/Latinoamérica de la Society of Cannabis Clinicians con la participación de investigadores Latinoamericanos. Grabado el viernes 18 de Septiembre 2020.

Acute effects of naturalistic THC vs. CBD use on recognition memory: a preliminary study

Authors: Tim Curran , Hélène Devillez , Sophie L. York Williams and L. Cinnamon Bidwell Published in Journal of Cannabis Research  2020 Abstract The ratio of Δ9-tetrahydrocannabinol (THC) to cannabidiol (CBD) varies widely across cannabis strains. CBD has opposite effects to THC on a variety of cognitive functions, including acute THC-induced memory impairments. However, additional…

Most Patients Believe Their Doctors Aren’t a “Good Source” of Information on Cannabis

Survey data reported that less than 20% of patients believe that their primary care providers are knowledgeable about cannabis-specific medical issues.

Perceptions and recommendation behaviors of dermatologists for medical cannabis: A pilot survey

Authors: Samuel Yeroushalmi, Kamaria Nelsona, Andrew Sparks, Adam Friedman Published in Complementary Therapies in Medicine September 2020 Abstract Objectives Evidence suggests that cannabinoids may provide therapeutic benefit to patients with dermatologic conditions. The recommendation behaviors of dermatologists with regards to recommending medical cannabis are unknown. We administered a pilot survey to evaluate dermatologists’ recommendation behaviors…

Ziva Cooper, PhD: Human Laboratory Studies of Cannabis: Probing Current Trends

Ziva Cooper, PhD presents “Controlled Human Laboratory Studies of Cannabis and Cannabinoids: Probing Current Trends in Medicinal Cannabis” at the SCC Quarterly Meeting. Dr. Cooper discusses research examining the differences between men and women in their response to the pain-relieving effects of cannabis, the potential for cannabis to reduce reliance on opioids, and therapeutic effects of cannabinoids in patient populations.

Medical marijuana certification for patients with sickle cell disease: a report of a single center experience

Authors: Susanna A. Curtis, Dana Lew, Jonathan Spodick, Jeanne E. Hendrickson, Caterina P. Minniti, John D. Roberts Published in Blood Advances August 2020 Abstract More than one-third of adults with sickle cell disease (SCD) report using cannabis-based products. Many states list SCD or pain as qualifying conditions for medical marijuana, but there are few data…

Cannabis use is associated with a lower risk of diabetes in chronic hepatitis C-infected patients (ANRS CO22 Hepather cohort)

Authors: Tangui Barré, Marie Libérée Nishimwe, Camelia Protopopescu, Fabienne Marcellin, Fabrice Carrat, Céline Dorival, Elisabeth Delarocque‐Astagneau, Dominique Larrey, Marc Bourlière, Ventzislava Petrov‐Sanchez, Mélanie Simony, Stanislas Pol, Hélène Fontaine, Patrizia Carrieri on behalf of the ANRS/AFEF Hepather study group Published in Journal of Viral Hepatitis August 2020 Abstract Chronic hepatitis C virus (HCV) infection is a…

A Survey Exploring the Relationship Between Cannabis Use Characteristics and Sexual Function in Men

Authors: Hriday P. Bhambhvani BS, Alex M.Kasman MD, Genester Wilson-King MD, Michael L. Eisenberg MD Published in Sexual Medicine September 2020 Abstract Introduction Cannabis is the most commonly used drug in the United States; however, the effects of cannabis use on male sexual function are poorly understood. Aim To characterize the contemporary landscape of cannabis…

Endometriosis & Cannabis Survey

Get involved in research to understand how women are self-treating for menstrual and endometriosis-related pain using cannabis and other techniques.

Frequent Cannabis Use and Cessation of Injection of Opioids, Vancouver, Canada, 2005-2018

Authors: Hudson Reddon, Kora DeBeck, M Eugenia Socias, Stephanie Lake, Huiru Dong, Mohammad Karamouzian, Kanna Hayashi, Thomas Kerr, M-J Milloy Published in American Journal of Public Health August 2020 Abstract Objectives To evaluate the impact of frequent cannabis use on injection cessation and injection relapse among people who inject drugs (PWID). Methods Three prospective cohorts…

A molecular basis for the anti-inflammatory and anti-fibrosis properties of cannabidiol

Authors: Falone Sunda, Afolake Arowolo Published in The FASEB Journal April 2020 Abstract Cannabidiol (CBD) is considered a non-psychoactive, antioxidant, and anti-inflammatory compound derived from the Cannabis sativa plant. There are various reports on the versatile function of CBD, including ameliorating chronic inflammation and fibrosis formation in several tissue types. However, only a hand full…